Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 58 out of 100. Risk factors

Topic: Risk, prevention and care in population studies

This issue of Medical Care includes a theoretical framework for conducting research on MCC, a review of existing MCC research methods and methodological gaps to be addressed, and the results of several research studies addressing MCC. Maciejewski and Bayliss5 suggest that quasiexperimental designs using large databases will be the workhorse design of the MCC field. Importantly, they showed that patients with the most common combinations of conditions (eg, diabetes, hyperlipidemia, and hypertension) are not the most costly. The authors conclude that patient and provider beliefs and preferences weigh heavily in statin prescribing decisions. In a sample of Veterans Administration (VA) patients with depression, some comorbidities (eg, cardio/cerebrovascular disease, peptic ulcer/GERD, or arthritis) increased the likelihood of receiving guideline-concordant care, whereas others (eg, substance or alcohol abuse) decreased the likelihood of receiving guideline-concordant care.16 Similarly, Domino et al17 showed that cancer screening and quality measures for single disease were generally lower among persons with MCC who also had mental illness, compared with those without mental illness. These findings emerged from an analysis of integrated Medicaid and mental health system data from the AHRQ-funded North Carolina Integrated Data for Researchers. Domino et al17 argue that quality of care for patients with behavioral conditions can serve as a benchmark for overall quality of care for all persons with MCC. The findings of these 3 studies suggest that specific morbidities such as behavioral health conditions and substance abuse may be sources of health disparity. As for other causes of health disparity, however, the reasons for and the outcomes associated with these variations warrant further investigation. The results of 2 studies address the appropriateness of extrapolating evidence of treatment effect from younger to older or from healthier to sicker populations. Prior research found that targeting normal hematocrit levels versus lower levels resulted in worse clinical outcomes in patients with ESRD. As a result, clinicians now typically aim for hematocrits in the 34.5%–39% range, although no evidence supports the use of this level versus lower hematocrit levels. Zhang and colleagues compared outcomes from ESRD patients with the middle-range hematocrit target versus outcomes for patients with hematocrits in the 30%–34.5% range. Their study showed no statistically s

Key findings

Why it matters

This issue of Medical Care includes a theoretical framework for research on multiple chronic conditions and results of several studies addressing MCC. It notes that patients with the most common combinations of conditions are not the most costly, and that cancer screening and quality measures for single disease were generally lower among persons with MCC who also had mental illness.

Study details

How this study scored 58/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 3 of 4; Study design 7 of 12; Strength of evidence 5 of 5; Peer-review validation 10 of 10; How recent 1 of 5; Sample size 4 of 4; Effect reported 2 of 3; Studied in people 3 of 3; Randomised / blinded 0 of 2; Times cited 4 of 7; Citations per year 2 of 5; Impact for its field and year 3 of 6; Cited by studies here 0 of 6; Still being cited 1 of 4; Senior author's track record 1 of 4; Institution's track record 2 of 3; Multi-centre collaboration 1 of 3; Indexed in PubMed 2 of 2; Free to read 0 of 2. Total 58 of 100.58 of 100 points earned42 not earned

Published in a peer-reviewed journal, and it is a longitudinal study following the same people over time. Scored zero for randomised / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Medical Care)
Journal's citation record 3 / 4 Medical Care: journal h-index 273 (OpenAlex, 2026-10-29)
Study design 7 / 12 A longitudinal study following the same people over time
Strength of evidence 5 / 5 Rated “high” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 1 / 5 2014 — within 20 year(s) of the newest study here
Sample size 4 / 4 110,000 participants
Effect reported 2 / 3 Effect reported as a number, without an interval or test
Studied in people 3 / 3 Studied in people (participant count stated)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 4 / 7 Cited 45 times (OpenAlex, 2026-10-10)
Citations per year 2 / 5 3.2 citations a year over 14 year(s) since 2014
Impact for its field and year 3 / 6 Cited 6.3× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 1 / 4 Cited 6 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 1 / 4 Last-listed author Jayasree Basu: h-index 18 (OpenAlex, whole career)
Institution's track record 2 / 3 Yale University: institution h-index 1,927 (OpenAlex)
Multi-centre collaboration 1 / 3 OpenAlex lists 2 institution(s) in 1 country
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 24561755)
Free to read 0 / 2 Behind a paywall — scores zero
Total 58 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it. The PubMed abstract is free.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

APA 7th

Tinetti, M. E., & Basu, J. (2014). Research on Multiple Chronic Conditions. Medical Care. https://doi.org/10.1097/mlr.0000000000000093

Vancouver

Tinetti ME, Basu J. Research on Multiple Chronic Conditions. Medical Care. 2014. doi:10.1097/mlr.0000000000000093. PMID: 24561755.

BibTeX

@article{tinetti2014-24561755,
  author  = {Tinetti, Mary E. and Basu, Jayasree},
  title   = {{Research on Multiple Chronic Conditions}},
  journal = {Medical Care},
  year    = {2014},
  doi     = {10.1097/mlr.0000000000000093},
  pmid    = {24561755},
  url     = {https://doi.org/10.1097/mlr.0000000000000093}
}

Related studies in Risk factors

Similar studies

More on Risk factors

See all studies in Risk factors →